In a recent study, Bulek et al. [99] have reported that epithelium-derived gasdermin D mediates nonlytic IL-1β release during experimental colitis and that gasdermin D deficiency substantially attenuates colitis severity; in this study, heterozygous control littermates (Gasdemin D+/−) were used. The gene discussed is GSDMD; the disease is colitis.